ABSTRACT For many years the development of thyrotoxicosis has been known to cause a deterioration in asthma but the mechanism is unknown. We have studied the effect of thyroid function on airway f8 adrenergic responsiveness in 10 hyperthyroid and six hypothyroid subjects before and after treatment of their thyroid disease. Airway adrenergic responsiveness was assessed by measuring specific airway conductance (sGaw) after increasing doses of inhaled salbutamol (10-410 ,ug). After treatment there was no difference in resting FEV1, sGaw, or thoracic gas volume.
FVC increased in the hyperthyroid subjects but did not change in the hypothyroid subjects. In the hyperthyroid subjects there was a significant increase in AsGaw after 35, 60, 110, and 410,g salbutamol; in sGaw after 60, 110, and 410 ,ug salbutamol; and in the area under the salbutamol dose response curve (AUC) after treatment of the thyroid disorder. In the hypothyroid subjects there was a significant reduction in sGaw after 10 and 60 ,ug salbutamol and in the AUC after treatment. When all subjects were considered, there was a negative correlation between the AUC and serum thyroxine values. These findings suggest that an inverse relationship exists between the level of thyroid function and airway ,B adrenergic responsiveness.
An interaction between thyroid disease and asthma has been recognised for over 50 years'-and confirmed in several recent reports.4-" When thyrotoxicosis occurs in patients with asthma bronchodilator and corticosteroid requirements increase. Asthma improves with antithyroid treatment and has in some instances relapsed on withdrawal of treatment.
The mechanism by which changes in thyroid function affect asthma is not known. It is unlikely that the respiratory muscle weakness'2 or pulmonary vascular congestion '3 inverse relationship between AUC and thyroxine values in the 16 patients before treatment (n = 16, r = -0-62, p < 0-025). This relationship remained when values from both visits for each subject were included (fig 3) .
Discussion
In this study FEV, FVC, and sGaw tended to increase after treatment in the hyperthyroid patients and to decrease in the hypothyroid patients. The differences were small, however, and the only significant change was the increase in FVC in the hyperthyroid patients. This is in keeping with the results of three previous studies of thyrotoxic patients, which found a small increase in vital capacity after treatment.'33 3 24 The reduction in vital capacity in thyrotoxicosis has been attributed to pulmonary congestion due to early thyrotoxic heart failure'3 and to respiratory muscle weakness, present in almost one third of thyrotoxic patients in one study.25 These changes are unlikely, however, to account for the deterioration in asthma and the 30 There is therefore at present no strong evidence for a direct effect of thyroxine on the /8 adrenoceptor.
An interaction between corticosteroid metabolism and adrenergic responsiveness has been described in animal models of thyroid disease. An increased response to noradrenaline was seen in rats given hydrocortisone and in hypothyroid rats with high circulating hydrocortisone concentrations.31 In thyrotoxic patients hydrocortisone clearance and metabolism is increased but circulating hydrocortisone concentrations appear to be normal, suggesting that adrenal compensation may be occurring. 32 Changes distal to the adrenoceptor are perhaps the most likely explanation for our findings. In hyperthyroid rat hearts the maximum contractile response to isoprenaline was reduced despite normal maximum protein kinase activation.33 Thyroxine may therefore be acting at a point dis(al to protein kinase. The flattening of the salbutamol dose response curve in thyrotoxic patients in this study and of the terbutaline dose response curve of the trachea from thyrotoxic guineapigs is compatible with a similar mechanism in airway smooth muscle.
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This study strongly suggests an inverse relationship between airway adrenergic responsiveness and the level of thyroid function. The mechanism underlying the relationship is obscure but the observation is supported by recent in vitro work and is the probable explanation for the deterioration seen in patients with asthma when they develop thyrotoxicosis.
